Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Nuclear Medicine/Radiopharmaceuticals Market, 2022 - Research and Markets

This image opens in the lightbox

News provided by

Research and Markets

27 Jul, 2016, 13:10 GMT

Share this article

Share toX

Share this article

Share toX

DUBLIN, July 27, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Nuclear Medicine/Radiopharmaceuticals Global Market - Forecast to 2022" report to their offering.

The global nuclear medicine/radiopharmaceutical market is expected to reach $9,275.3 million by 2022

Nuclear medicinal market is mainly classified into type (diagnosis & therapeutics), application and end-users. The global nuclear medicine market by diagnosis is further divided into SPECT and PET while therapeutics market is segmented into alpha radiation therapy, beta radiation therapy and brachytherapy.

Non-invasive nuclear medicine imaging technique provides functional information at both molecular and cellular level and helps measuring the uptake and turnover of target-specific radiotracers in tissue.

Radioisotopes are used in a wide variety of applications like oncology, cardiovascular and neurological disorders. But in recent times, advancements in the field of nuclear medicine and radioactive tracers have emerged to provide few practical methods for studying the limited metabolic activities of bones and teeth, hence has found a role in dental science research.

Nuclear medicinal market is mainly classified into type (diagnosis & therapeutics), application and end-users. The global nuclear medicine market by diagnosis is further divided into SPECT and PET while therapeutics market is segmented into alpha radiation therapy, beta radiation therapy and brachytherapy.

The nuclear medicine market end-users include medical, academic research laboratories and industries. The end-users by medical further segmented into hospitals and diagnostic centers.

The factors driving the growth of this market are increased application of radiopharmaceuticals, rise in public awareness, usage of hybrid imaging, abundance of radio pharmaceuticals, technological advancements; alpha radio immunotherapy based targeted cancer treatment and wide range of available products likely to propel the nuclear medicine market.

In addition to this, increasing need in emerging markets, production of radio pharmaceuticals from cyclotrons, efficient diagnosis and treatments, emerging radio isotopes, increasing therapeutic application areas and replacement of old/traditional equipment are some of the opportunities that are propelling the growth of the market. However, regulatory issues, high cost and supply shortage of isotopes, shorter half life of radiopharmaceuticals, and threat from traditional/alternative diagnostic procedures are hampering the growth of the market.

The threats for the nuclear medicine/radiopharmaceuticals market include huge capital investment and shortage of qualified technicians. The major problem area of nuclear medicine market is closure of reactors.

Key Topics Covered:

1 Executive Summary

2 Introduction

2.1 Key Take Aways

2.2 Report Description

2.3 Markets Covered

2.4 Stakeholders

2.5 Research Methodology

3 Market Analysis

3.1 Introduction

3.2 Market Segmentation

3.3 Factors Influencing Market

3.4 Problem Areas

3.5 Winning Imperatives

3.6 Regulatory Guidelines

3.7 Reimbursement Scenario & Challenges

3.8 Patent Trends

3.9 Supply Chain Analysis

3.10 List Of Potential New Reactors

3.11 Porter's Five Force Analysis

3.12 Market Share Analysis By Major Players

4 Radiopharmaceuticals By Type

4.1 Introduction

4.2 Diagnostics

4.3 Therapeutics

5 Global Nuclear Medicine Market By End-Users

5.1 Introduction

5.2 Medical

5.3 Academic Research Laboratories

5.4 Industries

6 Stable Isotopes

6.1 Introduction

6.2 Market Analysis

6.3 Stable Isotopes Market, By Isotopes

6.4 Stable Isotopes Market, By Applications

6.5 Stable Isotopes Market, By Geography

7 Regional Analysis

7.1 Introduction

7.2 North America

7.3 Europe

7.4 Asia-Pacific

7.5 Rest Of The World

8 Competitive Landscape

8.1 Introduction

8.2 New Product Launches

8.3 Agreements, Partnership, Collaboration & Joint Ventures

8.4 Approvals

8.5 Expansions

8.6 Mergers & Acquisitions

8.7 Other Developments

9 Major Player Profiles

9.1 Bayer Healthcare

9.2 Cardinal Health Inc.

9.3 Cambridge Isotope Laboratories Inc.

9.4 Ge Healthcare

9.5 Iba Group

9.6 Isotec Inc

9.7 Lantheus Medical Imaging Inc.

9.8 Mallinckrodt Plc

9.9 Nordion Inc

9.10 Ntp Radioisotopes Soc Ltd

9.11 Siemens Healthcare

9.12 Taiyo Nippon Sanso Corporation

Companies Mentioned

- Ablynx Nv

- Abx Gmbh

- Actinium Pharmaceuticals, Inc

- Advanced Accelerator Applications

- Advanced Medical Isotope Corporation

- Affibody Ab

- Algeta Asa

- Aptuit

- Areva Med

- Arronax

- Auspex Pharmaceuticals

- Bard Medicals

- Bavarian Nordic

- Bayer Healthcare

- Best Medical International, Inc

- Bio Analytical Research Corporation Laboratories

- Bio-Nucleonics,Inc

- Bracco Diagnostics Incs

- Btg International Ltd

- Bv Cyclotron Vu

- Cambridge Isotope Laboratories Inc.

- Cardinal Health Inc.

- Cellectar Biosciences

- Centre For Probe Development And Commercialization

- China Isotope Corporation

- Clarity'S Pharmaceuticals

- Coqui Pharmaceuticals

- Cortecnet

- Cp Medical

- Digirad Corporation

- Draximage Inc.

- Eckert & Ziegler Strahlen

- Eden Radioisotopes Llc

- Eli Lilly & Co

- Eurisotop

- Fujifilm Corporation

- Ge Healthcare

- Huayi Isotopes Co

- Iba Group

- Ibt-Bebig

- Idb Holland Bv

- Immunomedics

- Industrial Nuclear Company

- International Isotopes Inc.

- Invap S.E

- Iso Ray Medical Inc

- Iso Therapeutics Group, Llc

- Iso-Analytical Ltd

- Isoaid Llc

- Isoflex Isotope

- Isorad Ltd

- Isotec Inc

- Isotope Technologies Garching

- Ithemba Labs

- Joint Stock Company Isotope

- Lantheus Medical Imaging Inc

- Linde Group

- Mallinckrodt Plc

- Medi-Physics, Inc

- Medical Isotopes, Inc

- Mediso Medical Imaging Systems

- Memorial Sloan Kettering Cancer Center

- Navidea Biopharmaceuticals Inc

- Nihon Medi Physics Co Ltd

- Nordion Inc.

- Northstar Medical Technologies

- Ntp Radioisotopes Soc Ltd

- Octreopharm Sciences Gmbh

- Ostuka Pharmaceuticals Co Ltd

- Pars Isotope

- Peregrine Pharmaceuticals, Inc

- Perkin Elmer

- Perma-Fix Medical Sa

- Petnet Solution

- Philips Health Care

- Positron Corporation

- Radiomedix, Inc.

- Rotem Medical

- Royal Philips Electronics

- Sanofi

- Sercon Australia Pvt Ltd

- Sercon Ltd

- Shangai Research Institute Of Chemical Industry

- Shine Medical Technologies, Inc -

Siemens Healthcare

- Sievert

- Sirtex

- Source Production And Equipment Company+F191

- Spectrum Pharmaceuticals, Inc

- Spepharm Ag

- Stb Isotope Germany Gmbh

- Sterigenics International

- Steripet

- Tayyo Nippon Sanso Corporation

- Theragenics Corporation

- Thermo Fisher Scientific

- Toshiba Medical Systems Corporation

- Tracerco

- Trigon Biotechnology Inc

- Urenco

- Westinghouse Electric Company

- Zevacor Molecular

For more information visit http://www.researchandmarkets.com/research/rm8l4m/nuclear

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.